Sponsor Pipeline

Materia Medica Holding Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
4
Recruiting
5
Phase 3
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-10 NCT07754279 Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy Volunteers Phase 1 Completed
Active Trials by Phase
Phase 3
5
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07171099 Efficacy and Safety of Rengalin in the Treatment of ARVI Cough in Children Cough Recruiting
NCT06715891 Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in… Acute Respiratory Viral Infection Recruiting
NCT06901297 The Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult… Rhinosinusitis Recruiting
NCT07650227 Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of Acute… Bronchitis Recruiting
NCT06284265 Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of… Cystitis Chronic Active, Not Recruiting
Get alerts when Materia Medica Holding's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free